Press Releases

 Filter by Provider

LegalZoom.com, Inc. (Nasdaq: LZ), a leading online platform for legal services, today announced it has partnered with Design.com, a leading AI design platform for logo and graphic design, to give small businesses access to creating and protecting their brand. LegalZoom customers can now access Design.com's AI-powered logo generator directly within the LegalZoom platform. This integration allows users to ideate, design, and build their brand logo while also providing access to LegalZoom’s formation and trademark protection services in one place.

Insight Enterprises, Inc. (NASDAQ: NSIT) (the “Company”) today reported financial results for the quarter ended September 30, 2025. Results include:

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2025 and reviewed recent business highlights.

Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced that its Board of Directors has declared a 16% increase in the quarterly cash dividend from $0.49 to $0.57 per common share to be paid on December 12, 2025 to shareholders of record of CRA’s common stock as of the close of business on November 25, 2025. The Company expects to continue paying quarterly dividends, the declaration, timing and amounts of which remain subject to the discretion of CRA’s Board of Directors.

ReposiTrak (NYSE: TRAK), the world's largest food traceability and regulatory compliance network, built upon its proven inventory management and out-of-stock reduction SaaS platform, today announced that the Company plans to release earnings results for its fiscal 2026 first quarter after the market closes on Thursday, November 13, 2025.

Gannett Co., Inc. ("Gannett", "we", "us", "our", or the "Company") (NYSE: GCI) today reported its financial results for the third quarter ended September 30, 2025.

SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced it will present new preclinical and translational data from multiple investigational programs at two scientific conferences in November – the World ADC Conference in San Diego, California, and PEGS Europe, in Lisbon, Portugal.

Wells Fargo & Company (NYSE: WFC) said today that Chief Financial Officer Mike Santomassimo will present at the BancAnalysts Association of Boston Conference on Thursday, Nov. 6, 2025 at 8:10 a.m. ET.

BWX Technologies, Inc. (NYSE: BWXT) announced the award of a U.S. Naval Nuclear Propulsion Program contract from September 2025 totaling approximately $174 million for the manufacture of naval nuclear reactor fuel. The contract was awarded on Sept. 10, 2025.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced that it will report its third quarter 2025 financial and operating results on Thursday, November 6, 2025, following the close of the U.S. financial markets. Lineage management will also host a conference call and webcast on Thursday, November 6, 2025, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss its third quarter 2025 financial and operating results and to provide a business update.

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, announced today that it will host a conference call and webcast on Thursday November 13, 2025 at 4:30 PM eastern time to discuss its financial results for the quarter ended September 30, 2025. A press release detailing the results will be issued prior to the call.

Sun Auto Tire & Service today announced the appointment of Susie Long as Chief People Officer, a key addition to the company’s executive leadership team. Long brings decades of experience in organizational effectiveness, leadership development, and culture transformation - most recently serving as Chief Human Resources Officer for Bridgestone Americas West.

edatanetworks Inc. today announced the granting of U.S. Patent No. 12,277,836, by the United States Patent and Trademark Office (USPTO). This pioneer patent reflects a foundational invention that bridges immersive metaverse experiences with real-world economic and social outcomes – defining a new category of engagement where virtual interaction, responsible gaming, and AI-enabled philanthropy converge.

Centerline, a TrueBlue (NYSE: TBI) company and a leader in transportation staffing, has been named a Top Company for Women to Work in Transportation by the Women in Trucking Association (WIT). Centerline earned one of the highest vote totals from industry professionals and has also been named to the program’s “Elite 30.” The company will be recognized during WIT’s 2025 Accelerate! Conference & Expo in Dallas, November 9-12, 2025.

Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced financial and operating results for the third quarter ended September 30, 2025, as well as certain events occurring subsequent to quarter end.

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November:

-- Posters will review product characterization and manufacturing data on T-knife’s lead program, TK-6302, a supercharged PRAME T cell receptor therapy that is advancing towards the clinic, with the filing of a Clinical Trial Application planned in Q4 2025 -- PRAME is a validated target and is expressed in cancers of the skin, uterus, ovaries, lungs, breasts, esophagus, kidneys, cervix, and head & neck

Conference Call and Webcast Scheduled for Thursday, November 6th, 2025, at 10:00 AM ET

Authorization Positions Company to Generate Non-Dilutive, Tax-Free Capital to Support Growth, Innovation, and Sustainable Expansion

CHARLOTTE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Kinetic, a leading residential and business fiber internet provider, announced today that it has teamed up with eero, an Amazon company, to provide consumers with Wi-Fi 7, the fastest and most advanced Wi-Fi technology available today.

BASKING RIDGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that the Company will report its financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the close of trading and will host a conference call at 4:30 p.m. Eastern time. To join the live conference call, please refer to the dial-in information provided below.

OVERLAND PARK, Kan., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Madrid-based Indra Group has announced an investment of $50 million in Indra Group USA to construct and equip a new manufacturing facility that will expand its industrial and technological capacity to produce radars, ground-to-air communication radios, and other air traffic surveillance and navigation systems. The new facility, to be located in the Kansas City area, is expected to be operational by early 2026 and will create more than 200 new jobs over the next three years.

3Q 2025 Total revenue grew 25% year-over-year to $59.4 million driven by 42% year-over-year growth in Payor revenue

NOVATO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that the first patient has been dosed in the Aurora study (NCT07157254) evaluating the efficacy and safety of GTX-102 (apazunersen), an investigational antisense oligonucleotide (ASO) for Angelman syndrome (AS). Data from the Aurora study will expand the population of Angelman patients treated to include both younger and older patients and those with other non-deletion AS genotypes not included in the Phase 3 Aspire study. The fully enrolled Phase 3 Aspire study (NCT06617429) of GTX-102 is focused on patients aged 4 to 17 years with a genetically confirmed diagnosis of full maternal UBE3A gene deletion.

Survey showcases consumer attitudes towards health plans’ use of AI

OREM, Utah, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SunPower Inc. (Nasdaq: SPWR) a solar technology, services, and installation company, this morning announced the successful integration of the Sunder salesforce into the company — as SunPower continues to execute on plan and expects to achieve record revenue of $83.3 million and record operating income of $3.5 million in Q4 2025.

NEWPORT BEACH, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: PMGC) (“PMGC” or the “Company”), a diversified public holding company executing a targeted roll-up strategy in U.S.-based manufacturing, is pleased to announce that its wholly owned subsidiary, AGA Precision Systems LLC (“AGA Precision Systems” or “AGA”), has completed International Traffic in Arms Regulations (ITAR) registration and is in compliance with ITAR. The ITAR is administered by the U.S. State Department’s Directorate of Defense Trade Controls, which controls the export and import of defense articles and services.

COOTAMUNDRA, Australia, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited (the “Company”) (NASDAQ: COOT), a manufacturer and seller of sustainable edible oils to customers globally, today announced it has received written notice from The Nasdaq Stock Market (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1). This confirmation was followed by Nasdaq’s approval of the Company’s application to transfer the listing of its securities to The Nasdaq Capital Market, effective at the opening of business on October 31, 2025.  

BRISBANE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its third quarter financial results after the close of the U.S. markets on Thursday November 6, 2025. Following the release, the company will host a live conference call and webcast at 4:30 p.m. ET.

All amounts in U.S. dollars unless otherwise stated 

Fluke data reveals 61 percent of manufacturers hit in the past year; outages stretch up to 72 hours and threaten profitability at the board level.

LONGBOAT KEY, FL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Rumble Inc. (NASDAQ: RUM) (“Rumble” or the “Company”), the video-sharing platform and cloud services provider, today announced that it will release financial results for the fiscal quarter ended September 30, 2025 after market close on Wednesday, November 12, 2025. The Company will host a conference call on the same day at 5:00 p.m. Eastern Time.

ST. LOUIS, Oct. 30, 2025 (GLOBE NEWSWIRE) -- MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that data from the Company’s transdermal GFR technology has been accepted for an oral presentation at the upcoming American Society of Nephrology (ASN) Kidney Week 2025 in Houston, TX, November 5-9, 2025.

$1.5 billion acquisition strengthens global leadership in organ technology and accelerates progress toward making every organ count

SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present poster presentations at ObesityWeek® 2025, taking place November 4-7, 2025 in Atlanta, Georgia.

NAARDEN, The Netherlands and MIAMI, Oct. 30, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that it will present additional safety and efficacy data from the pivotal Phase 3 BROOKLYN, BROADWAY and TANDEM trials at the 2025 American Heart Association (AHA) Scientific Sessions, taking place November 7 – 10, 2025 in New Orleans, Louisiana. Additionally, NewAmsterdam announced that company management will participate in three upcoming investor conferences. Details are as follows:

Cloudbrink AI Platform Gives IT and Security Teams the Control, Visibility, and Performance Needed to Ensure Safe AI Adoption in the Enterprise

Agreement Strengthens Plug’s Global Portfolio of Utility-Scale Hydrogen and Sustainable Fuel Developments

WESTLAKE VILLAGE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the commercial launch of ZORYVE® (roflumilast) cream 0.05% for the treatment of mild to moderate atopic dermatitis in children ages 2 to 5 years in the United States.

With the majority of Americans saying they feel unprepared for grid instability, electricity outages, and extreme weather, Sunrun offers peace of mind with home battery storage and solar

HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. 

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, today announced the presentation of new data on its first therapeutic candidate from its RedTail platform, CLD-401, at the Society of Immunotherapy for Cancer (SITC) Annual Meeting.

Michael Napodano Appointed CEO Of Operative Media

PALO ALTO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, today announced the formation of its Privacy Advisory Board. Composed of leading experts in health data privacy, data ethics, and consumer advocacy, the Board will provide strategic guidance on the protection of member information and the organization’s responsible stewardship of personal data.

The "Latin America Buy Now Pay Later Business and Investment Opportunities Databook - 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis, Business Model, Demographics - Q3 2025 Update" report has been added to ResearchAndMarkets.com's offering.

Milestone advances MEAI-based therapy targeting a global Alcohol Use Disorder treatment market projected to surpass $20 billion by 2032

BlockWoods is a leading Crypto Marketing agency with creative marketing experts to scale your business. Join hands with us to emerge as an iconic brand.

Cleveland-Cliffs Inc. (NYSE: CLF) is pleased to announce that POSCO, Korea’s largest steelmaker and the world’s third largest steelmaker outside of China, is its strategic partner under the previously disclosed transformative Memorandum of Understanding. The MoU between the two companies was executed on September 17, 2025. With the recent completion of the new U.S. and Korea trade agreement, cooperation between the two nations’ industrial sectors will be further reinforced by the POSCO-Cliffs partnership.